Abstract
In this issue of Blood, Dejoie et al demonstrate the superiority of serum free light chain (sFLC) testing in the response measurement of light-chain multiple myeloma (MM) over urine in accuracy, sensitivity, and prognosis.1
Original language | English (US) |
---|---|
Pages (from-to) | 2873-2874 |
Number of pages | 2 |
Journal | Blood |
Volume | 128 |
Issue number | 25 |
DOIs |
|
State | Published - Dec 22 2016 |
ASJC Scopus subject areas
- Biochemistry
- Immunology
- Hematology
- Cell Biology